Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Shares Outstanding (Diluted Average) (2019 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Shares Outstanding (Diluted Average) for 9 consecutive years, with $2.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 83.5% to $2.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.6 million, a 83.5% increase, with the full-year FY2024 number at $1.5 million, up 5.17% from a year prior.
  • Shares Outstanding (Diluted Average) was $2.6 million for Q3 2025 at Creative Medical Technology Holdings, up from $2.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $1.2 billion in Q1 2021 to a low of $1.4 million in Q3 2024.
  • A 5-year average of $175.3 million and a median of $2.4 million in 2021 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): soared 473.73% in 2022, then crashed 87.12% in 2023.
  • Creative Medical Technology Holdings' Shares Outstanding (Diluted Average) stood at $3.2 million in 2021, then surged by 236.51% to $10.9 million in 2022, then plummeted by 87.12% to $1.4 million in 2023, then increased by 5.17% to $1.5 million in 2024, then skyrocketed by 74.31% to $2.6 million in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Shares Outstanding (Diluted Average) are $2.6 million (Q3 2025), $2.3 million (Q2 2025), and $2.0 million (Q1 2025).